Interfacial interaction between transmembrane ocular mucins and adhesive polymers and dendrimers analyzed by surface plasmon resonance

Pharmaceutical Research

Volumn 29, Issue 8, 2012, Pages 2329-2340

  Bravo Osuna, I ^a   Noiray, M ^b   Briand, E ^b   Woodward, A M ^c   Argueso P ^c   Martínez, I T Molina ^a   Herrero Vanrell, R ^a   Ponchel, G ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIV PARIS SUD   (France)

^c SCHEPENS EYE RESEARCH INSTITUTE   (United States)

Author keywords

Chitosan; Mucoadhesion; Ocular transmembrane mucins; Polyamidoamine (PAMAM) dendrimers; Surface plasmon resonance (SPR)

Indexed keywords

CARBOXYMETHYLCELLULOSE; CHITOSAN; DENDRIMER; HYALURONIC ACID; HYDROXYPROPYLMETHYLCELLULOSE; MUCIN; POLYAMIDOAMINE; POLYMER;

ARTICLE; BIOCHIP; BIOSENSOR; CHEMICAL INTERACTION; CONCENTRATION (PARAMETERS); DIFFUSION; DRUG BIOAVAILABILITY; DRUG RETENTION; HUMAN; HUMAN CELL; MUCOADHESION; PRIORITY JOURNAL; QUARTZ CRYSTAL MICROBALANCE; SURFACE PLASMON RESONANCE; X RAY PHOTOELECTRON SPECTROSCOPY;

CARBOXYMETHYLCELLULOSE SODIUM; CELL LINE; CHITOSAN; CORNEA; DENDRIMERS; HUMANS; HYALURONIC ACID; METHYLCELLULOSE; MUCINS; OPHTHALMIC SOLUTIONS; PHOTOELECTRON SPECTROSCOPY; QUARTZ CRYSTAL MICROBALANCE TECHNIQUES; SURFACE PLASMON RESONANCE;

EID: 84864444446     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0761-1     Document Type: Article

References (41)

1. Durrani AM, Farr SJ, Kellaway IW. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye. Int J Pharmaceut. 1995;118:243-50.
2. Hartmann V, Keipert S. Physico-chemical, in vitro and in vivo characterisation of polymers for ocular use. Pharmazie. 2000;55(6):440-3.
3. SnibsonGR,Greaves JL, SoperNDW, et al. Ocular surface residence times of artificial tear solutions. Cornea. 1992;11(4):288-93.
4. Mantelli F, Argüeso P. Functions of ocular surface mucins in health and disease. Curr Opin Allergy Clin Immunol. 2008;8 (5):477-83.
5. Guzman-Aranguez A, Argüeso P. Structure and biological roles of mucin-typeO-glycans at the ocular surface.Ocul Surf. 2010;8(1):8-17.
6. Gipson IK, Hori Y, Argüeso P. Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf. 2004;2(2):131-48.
7. Bin Choy Y, Park JH, Prausnitz MR. Mucoadhesive microparticles engineered of ophthalmic drug delivery. J Phys Chem Solid. 2008;69(5-6):1533-6.
8. Vandamme TF, Brobeck L. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J Contr Release. 2005;102(1):23-38.
9. Fan X, White IM, Shopova SI, Zhu H, Suter JD, Sun Y. Sensitive optical biosensors for unlabeled targets: a review. Anal Chim Acta. 2008;620:8-26.
10. Takeuchi H, Thongborisute J, Matsui Y, Sugihara H, Yamamoto H, Kawashima Y. Novel mucoadhesion test for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev. 2005;57:1583-94.
11. Chayed S, Winnik M. In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur J Pharm Biopharm. 2007;65:363-70.
12. Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci. 2003;44(6):2496-506.
13. Argüeso P, Gipson IK. Quantitative analysis of mucins in mucosal secretions using indirect enzyme-linked immunosorbent assay. Meth Mol Biol. 2006;347:277-88.
14. Thornton DJ, Khan N, Mehrotra R, Howard M, Veerman E, Packer NH, et al. Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. Glycobiology. 1999;9(3):293-302.
15. Rodahl M, Höök F, Kasemo B. QCM operation in liquids: an explanation of measured variations in frequency and Q factor with liquid conductivity. Anal Chem. 1996;68:2219-27.
16. Sauerbrey G. Verwendung von Schwingquarzen zurWägung dünner Schichten und zur Mikrowägung Z. Phys. 1959;155:206-22.
17. Vionova MV, Rodahl M, Jonson M, Kasemo B. Viscoelastic accustic response of layered polymer films at fluid-solid interfaces. Continuum mechanism approach. Phys Scr. 1999;59:391-6.
18. Andrés-Guerrero V, Molina-Martínez IT, Peral A, de las Heras B, Pintor J, Herrero-Vanrell R. The use of mucoadhesive polymers to enhance the hypotensive effect of a melatonin analog (5-MCA-NAT) in rabbit eyes. Invest Ophthalmol Vis Sci. 2011;52(3):1507-15.
19. De la Fuente M, Raviña M, Policelli P, Sanchez A, Seijo B, Alonso MJ. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev. 2010;62:100-17.
20. Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosanpoly( isobutylcyanoacrylate) core-shell nanoparticles. Biomat. 2007;28:233-43.
21. Makky A, Michel JP,Kasselouri A, Briand E, Maillard Ph, Rosilio V. Evaluation of the specific interactions between glycodendrimeric porphyrins, free or incorporated into liposomes, and concanavaline a by fluorescence spectroscopy, surface pressure, and QCM-D measurements. Langmuir. 2010;26(15):12761-8.
22. Halthur TJ, Arnebrant T, Macakova L, Feiler A. Sequential adsorption of bovine mucin and lectoperoxidase to various substrates studies with quartz crystal microbalance with dissipation. Langmuir. 2010;26(7):4901-8.
23. Feldoto Z, Pettersson T, Dedinaite A. Mucin-electrolyte interactions at the solid-liquid interface probed by QCM-D. Langmuir. 2008;24:2248-3357.
24. Komolov KE, Senin II, Philippov PP, Koch KW. Surface plasmon resonance study ofGprotein/receptor coupling in a lipid bilayer-free system. Anal Chem. 2006;78:1228-34.
25. Uchida H, Furtain K, Kawai Y, Kitazawa H, Horii A, Shiba K, et al. A new assay using surface plasmon resonance (SPR) to determine binding of the Lactobacillus acidophilus group to human colonic mucin. Biosci Biotechnol Biochem. 2004;68(5):1004-10.
26. Russel BG, Moddeman WE, Birkbeck JC, Wright SE, Millington DS, Stevens RD, et al. Surface structure of human mucin using Xray protpelectron spectroscopy. Biospectroscopy. 1998;4:257-66.
27. Kesimer M, Sheehan JK. Analyzing the functions of large glycoconjugates through the dissipative properties of their absorbed layers using the gel-forming mucin MUC5B as an example. Glycobiology. 2008;18(6):463-72.
28. Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71:505-18.
29. Ponchel G, Touchard F, Duchene D, Peppas NA. Bioadhesive analysis of controlled-release systems I. Fracture and interpenetration analysis of poly(acryl acid)-containing systems. J Contr Release. 1987;5:129-41.
30. Mortazavi SA, Smart J. An investigation into the role of water movement and mucus gel hydration in mucoadhesion. J Contr Release. 1993;25:197-203.
31. Pimenta C, Lenaerts V, Cadieux C, Raymond P, Juhasz J, Simard MA, et al. Mucoadhesion of hydroxypropylmethacrylate nanoparticles to ral tintestinal ileal segments in vitro. Pharm Res. 1990;7:49-53.
32. Rao KVR, Buri P. A novel in situ method to test polymers ad coated microparticles bioadhesion. Int J Pharm. 1990;52:265-70.
33. Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev. 2005;57(11):1595-639.
34. Lee S, Müller M, Rezwan K, Spencer ND. Porcine gastric mucin (PGM) at the water/poly(dimethylsiloxane) (PDMS) interface: influence of pH and ionic strength on its conformation, adsorption, and aqueous lubrication properties. Langmuir. 2005;21(18):8344-53.
35. Liu Q, Wang Y. Development of an ex vivo method for evaluation of precorneal residence of topical ophthalmic formulations. AAPS Pharmaceut Sci Tech. 2009;10(3):796-805.
36. Saettone MF, Monti D, Torracca MT, Chetoni P. Mucoadhesive ophthalmic vehicle: evaluation of polymeric low-viscosity formulations. J Pharm. 1994;10(1):83-92.
37. Holden CA, Tyagi P, Thakur A, Kadam R, Jadhav G, Kompella UB, Yang H. Polyamidoamine dendrimer hydrogel for enhanced delivery of antiglaucoma drugs. Nanomedicine Nanotechnol Biol Med. 2011 In press
38. Boas U, Heegaard MH. Dendrimers in drug research. Chem Soc Rev. 2004;33:43-63.
39. Griffiths PC, Occhipinti P, Morris C, Heenan RK, King SM, Gumbleton M. PSGE-NMR and SANS studies of the interaction of model polymer therapeutics with mucins. Biomacromolecules. 2010;11:120-5.
40. Liu Y, Bryantsev VS, Diallo MS, Goddard III WA. PAMAM dendrimers undergo pH responsive conformational changes without swelling. J Am Chem Soc. 2009;131:2798-9.
41. Andersson K, Hamalainen M, Maemqvist M. Identification and optimization of regeneration conditions for affinity-based biosensors assays. A multivariate cocktail approach. Anal Chem. 1999;71:2475-81.